- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SIENTRA Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 374,80 | -0,16 % | Ausbruch dank Novo Nordisk, UnitedHealth und Johnson & Johnson? | Der Chart sieht spannend aus. Dank der zuletzt soliden Performance von Aktien wie UnitedHealth, Novo Nordisk oder Johnson & Johnson könnte der Index "Aktien für immer" bald auf ein neues Jahreshoch... ► Artikel lesen | |
| THERMO FISHER | 448,70 | -0,42 % | Bernstein SocGen nimmt Coverage für Thermo Fisher mit "Market Perform" wieder auf | ||
| TELADOC HEALTH | 7,310 | -0,63 % | Teladoc Health, Inc.: Teladoc Health Reports First Quarter 2026 Results | NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2026 ("First... ► Artikel lesen | |
| RESMED | 175,10 | -0,43 % | Should I buy CSL and ResMed shares right now? | ||
| ATOSSA THERAPEUTICS | 1,510 | -7,93 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| HENRY SCHEIN | 74,00 | -1,33 % | Is Henry Schein Stock Underperforming the Nasdaq? | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| ZIMMER BIOMET | 79,90 | -2,20 % | Dividendenbekanntmachungen (25.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AJISEN CHINA HOLDINGS LTD KYG0192S1093 0,113 HKD 0,0126 EUR ALLGAEUER BRAUHAUS AG DE0005035505 - 2 EUR ASYMCHEM LABORATORIES TIANJIN... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results | Revenues increased 48% in Q4 2026 compared to Q4 2025, and 37% in FY 2026 compared to FY 2025United States revenues increased 194% in Q4 2026 compared to Q4 2025 and 117% in FY 2026 compared to FY 2025Net... ► Artikel lesen | |
| PETMED EXPRESS | 1,494 | -1,97 % | PETMED EXPRESS INC - 8-K, Current Report | ||
| TANDEM DIABETES | 14,100 | -1,40 % | Deutsche Bank initiates Tandem Diabetes stock with hold rating | ||
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| QUIDELORTHO | 12,100 | 0,00 % | QuidelOrtho Corporation: QuidelOrtho Appoints Micah Young as Chief Financial Officer | Seasoned medical technology finance executive brings more than two decades of leadership at global public companies SAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq:... ► Artikel lesen | |
| VERU | 3,000 | -0,33 % | Top Biotech Gainers: VERU Teams Up With NVO, ABSI On Watch, ALVO Resubmits BLAs To FDA... | REYKJAVIK (dpa-AFX) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 181,45 | -1,52 % | Quest Diagnostics' Haystack MRD Test Wins New York State Approval For Solid Tumor Monitoring | WASHINGTON (dpa-AFX) - Wednesday, Quest Diagnostics Inc. (DGX) announced that the New York State Department of Health's Clinical Laboratory Evaluation Program has approved the company's Haystack... ► Artikel lesen |
Das Unternehmen SIENTRA INC kann der Branche Gesundheitswesen zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIENTRA INC finden Sie auf Wallstreet Online.